Erythropoietin depletes iron stores: antioxidant neuroprotection for ischemic stroke?
Bailey
Damian Miles
DM
Robach
Paul
P
Thomsen
Jonas Juhl
JJ
Lundby
Carsten
C
D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use*; D001923:Brain Chemistry / Q000187:drug effects; D002545:Brain Ischemia / Q000188:drug therapy* / Q000378:metabolism; D002384:Catalysis; D002614:Chelating Agents / Q000627:therapeutic use; D004921:Erythropoietin / Q000494:pharmacology / Q000627:therapeutic use*; D005293:Ferritins / Q000097:blood; D005296:Ferrous Compounds / Q000008:administration & dosage; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007501:Iron / Q000378:metabolism*; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D011994:Recombinant Proteins; D014168:Transferrin / Q000032:analysis
D000975:Antioxidants; D002614:Chelating Agents; D005296:Ferrous Compounds; D006454:Hemoglobins; D018696:Neuroprotective Agents; D011994:Recombinant Proteins; D014168:Transferrin; D004921:Erythropoietin; C020748:ferrous sulfate; D005293:Ferritins; D007501:Iron